Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

The New England Journal of Medicine
M M KitahataE H Wagner

Abstract

Previous studies have found that patients with the acquired immunodeficiency syndrome (AIDS) who are admitted to hospitals that admit many such patients have lower mortality rates than patients in hospitals with less experience with AIDS. We examined the relation between physicians' experience with AIDS and the survival of their patients with AIDS. We studied 403 adult male patients enrolled in a staff-model health maintenance organization in whom first AIDS-defining illnesses were diagnosed from 1984 through mid-1994; we determined that these illnesses met the 1987 case definition of the Centers for Disease Control. We defined three levels of experience for the patients' 125 primary care physicians according to their experience with AIDS during residency training and the cumulative number of patients with AIDS they had cared for in their practices. The median survival of the patients of physicians with the least experience in the management of AIDS was 14 months, as compared with 26 months for the patients of physicians with the most experience (P<0.001). Controlling for the severity of illness and the year of diagnosis, we found that the patients cared for by physicians with the most experience had a 31 percent lower risk of ...Continue Reading

References

Dec 20, 1979·The New England Journal of Medicine·H S LuftA C Enthoven
Apr 16, 1992·The New England Journal of Medicine·N M GrahamJ P Phair
Jan 1, 1991·Journal of General Internal Medicine·M D Smith
Sep 1, 1990·Journal of General Internal Medicine·H J MakadonT L Delbanco
Nov 15, 1988·Annals of Internal Medicine·D W NorthfeltM F Shapiro
Sep 1, 1994·Journal of Clinical Epidemiology·N M GrahamS L Zucconi
Dec 23, 1993·The New England Journal of Medicine·D R HooverR A Kaslow
Apr 13, 1994·JAMA : the Journal of the American Medical Association·J D LundgrenJ O Nielsen

❮ Previous
Next ❯

Citations

Oct 14, 2000·New Directions for Mental Health Services·J S Kobayashi, W L Standridge
Aug 1, 1997·Journal of General Internal Medicine·C R HorsburghR Silver
Apr 9, 2005·Der Internist·M Battegay, U Flückiger
Jun 27, 2012·Current HIV/AIDS Reports·Philip M Grant, Andrew R Zolopa
Nov 14, 1998·Disease-a-month : DM·H W HorowitzG P Wormser
Sep 21, 1996·Lancet·J J Lipsky
Jul 27, 1996·Lancet·M B Feinberg
May 26, 1999·The Journal of Infection·A R MackenzieC C Smith
Jul 6, 1997·Health Policy·M J PostmaJ C Jager
Jul 1, 1997·Critical Care Clinics·M J CowanS J Levine
Feb 23, 1999·Kidney International·J A WinstonP E Klotman
Jan 20, 2004·Advances in Renal Replacement Therapy·Lesley Ann Stevens, Adeera Levin
Mar 14, 1996·The New England Journal of Medicine·P A Volberding
Aug 1, 1996·The New England Journal of Medicine·R J Coker, M C Poznansky
Aug 15, 1996·The New England Journal of Medicine·R M Wachter, L Goldman
Sep 11, 1997·The New England Journal of Medicine·R Steinbrook
Aug 11, 2001·The New England Journal of Medicine·J S Montaner, J W Mellors
May 2, 2003·The New England Journal of Medicine·Steven J ReynoldsRobert C Bollinger
Mar 17, 2012·Health Care for Women International·Amelia K BoehmeMirjam-Colette Kempf
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E RiberaA Pahissa
May 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Tice
Apr 20, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P A GrossS A Bozette
Apr 10, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Russell M PetrakR Brooks Gainer
Jun 13, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W A DuffusUNKNOWN Antiretroviral Treatment and Access Studies Study Group
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marvin J Tenenbaum
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C William WesterRichard G Marlink
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shawn L FultzAmy C Justice
Apr 5, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bijal ShahAmita Gupta
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John A SchneiderDavid O Meltzer
Jul 11, 2001·AIDS Patient Care and STDs·B GerbertP A Volberding
May 10, 2003·AIDS Patient Care and STDs·Margaret Chesney
Nov 1, 2003·AIDS Patient Care and STDs·Kimberly Y SmithDiana Williamson
Aug 17, 2004·AIDS Patient Care and STDs·Jamie FeldmanMark Millis
Feb 1, 1997·AIDS Patient Care and STDs· Mainous AG 3rdS C Matheny

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
C L BrosgartD I Abrams
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
D J SextonB H Wade
© 2021 Meta ULC. All rights reserved